Altogether, we identified immunological (IL-13/IL-4/STAT6), genetic (rs76562819), and epithelial differentiation factors that regulate the expression of CAPN14. These results are important because calpain-14 represents a candidate for treatment and prevention of EoE. The gene discussed is STAT6; the disease is eosinophilic esophagitis.